These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 5907365)
21. Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomas. Dupertuis YM; Xiao WH; De Tribolet N; Pichard C; Slosman DO; Bischof Delaloye A; Buchegger F Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):499-505. PubMed ID: 11914888 [TBL] [Abstract][Full Text] [Related]
22. Incorporation of iododeoxyuridine into neoplastic DNA: a fraudulent magic bullet? Calabresi P; Curt G Hepatology; 1990 Jan; 11(1):145-6. PubMed ID: 2295464 [No Abstract] [Full Text] [Related]
23. Replication and 5-iodo-2'-deoxyuridine-3-H incorporation by tumor and normal cells. Hoffman J; Post J Cancer Res; 1966 Jul; 26(7):1313-8. PubMed ID: 5911571 [No Abstract] [Full Text] [Related]
24. Pharmacodynamics of 5-iodo-2'-deoxyuridine in VX2 tumor-bearing rabbits. Stetson PL; Yang ZM; Ensminger WD J Natl Cancer Inst; 1989 Dec; 81(24):1925-6. PubMed ID: 2593171 [No Abstract] [Full Text] [Related]
25. Retention of labelled 5-iodo-2-deoxyuridine after intratumorous injection as a possible indicator of the cellular kinetics. Andrysek O; Bláhová E; Gregora V Czech Med; 1984; 7(3):161-6. PubMed ID: 6499600 [TBL] [Abstract][Full Text] [Related]
26. Iodo- and bromodeoxyuridine are excised at different rates from DNA of mouse tongue keratinocytes in vitro. Hume WJ; Saffhill R Chem Biol Interact; 1986 Nov; 60(2):227-32. PubMed ID: 2431799 [TBL] [Abstract][Full Text] [Related]
27. ICI D1694 and idoxuridine: a synergistic antitumor combination. Pressacco J; Hedley DW; Erlichman C Cancer Res; 1994 Jul; 54(14):3772-8. PubMed ID: 8033097 [TBL] [Abstract][Full Text] [Related]
28. The nucleus is the target for radiation-induced chromosomal instability. Kaplan MI; Morgan WF Radiat Res; 1998 Oct; 150(4):382-90. PubMed ID: 9768851 [TBL] [Abstract][Full Text] [Related]
29. Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine. Fischer PH; Weddle MA; Mossie RD Mol Pharmacol; 1983 May; 23(3):709-16. PubMed ID: 6865913 [TBL] [Abstract][Full Text] [Related]
30. Specificity of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2'-deoxyuridine. Woodman PW; Sarrif AM; Heidelberger C Cancer Res; 1980 Mar; 40(3):507-11. PubMed ID: 6451286 [TBL] [Abstract][Full Text] [Related]
31. [Thymine-2'-desoxypentopyranodises as inhibitors of uridine desoxyuridine phosphorylase. Configuration-effect relations]. Etzold G; Preussel B; Hintsche R; Langen P Acta Biol Med Ger; 1968; 20(4):437-42. PubMed ID: 5696134 [No Abstract] [Full Text] [Related]
32. Feline viral rhinotracheitis virus: explant and cocultivation studies on tissues collected from persistently infected cats. Ellis TM Res Vet Sci; 1982 Nov; 33(3):270-4. PubMed ID: 6296952 [TBL] [Abstract][Full Text] [Related]
33. Stabilisation of nucleic acid secondary structures by oligonucleotides with an additional nucleobase; synthesis and incorporation of 2'-deoxy-2'-C-(2-(thymine-1-yl)ethyl)uridine. Pedersen SL; Nielsen P Org Biomol Chem; 2005 Oct; 3(19):3570-5. PubMed ID: 16172696 [TBL] [Abstract][Full Text] [Related]
34. [Pharmacokinetics of 5-iodo-2-deoxyuridine introduced into the eye tissues with soft contact lenses (experimental study)]. Shchipanova AI; Maĭchuk IuF; Babich GA; Kivaev AA; Zelenskaia MV Vestn Oftalmol; 1982; (6):74-6. PubMed ID: 7157576 [No Abstract] [Full Text] [Related]
35. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model. Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535 [TBL] [Abstract][Full Text] [Related]
36. Effect of blood serum from irradiated mice on the incorporation of DNA, RNA and protein precursor in L929 cells. A sensitive assay for measuring low dose response. Mühlensiepen H; Porschen W; Feinendegen LE Strahlentherapie; 1983 Aug; 159(8):513-7. PubMed ID: 6194588 [TBL] [Abstract][Full Text] [Related]
37. Correspondence re: J.A. Knol et al., Incorporation of 5-bromo-2-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion. Cancer Res., 55: 3687-3691, 1995. Kinsella TJ Cancer Res; 1996 Jun; 56(11):2677-8. PubMed ID: 8653716 [No Abstract] [Full Text] [Related]
38. Are there unexploited possibilities for the therapeutic use of radioactive and stable isotopically labeled DNA precursors and extracorporeal irradiation of the blood in treatment of leukemia? Cronkite EP; Fairchild RG; Miller ME Blood Cells; 1983; 9(1):107-23. PubMed ID: 6344933 [TBL] [Abstract][Full Text] [Related]
39. [Regulation of enzyme activities involved in pyrimidine synthesis and its application to cancer chemotherapy]. Shirasaka T; Fujii S Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):760-8. PubMed ID: 6424581 [TBL] [Abstract][Full Text] [Related]
40. 5-allyl-2'-deoxyuridine inhibition of nucleoside phosphorylase in HeLa cells containing mycoplasma. Holland JF; Korn R; O'Malley J; Minnemeyer HJ; Tieckelmann H Cancer Res; 1967 Oct; 27(10):1867-73. PubMed ID: 6064964 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]